Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX3CPC
|
||||
| Drug Name |
4-{[3-(Methyloxy)phenyl]methyl}-2-{[(2R)-1-methyl-2-pyrrolidinyl]methyl}-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL1767147
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H25N3O2
|
||||
| Canonical SMILES |
COc1cccc(CC2=NN(C[C@H]3CCCN3C)C(=O)c4ccccc24)c1
|
||||
| InChI |
InChI=1S/C22H25N3O2/c1-24-12-6-8-17(24)15-25-22(26)20-11-4-3-10-19(20)21(23-25)14-16-7-5-9-18(13-16)27-2/h3-5,7,9-11,13,17H,6,8,12,14-15H2,1-2H3/t17-/m1/s1
|
||||
| InChIKey |
JWDZDXFXHWMSGR-QGZVFWFLSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.